Jitka A.I. Virag

Dr. Jitka A.I. Virag

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2004 in Nature
Verified
Journal Article
Closed access
CMCharles E. Murry
Charles E. Murry
MSMark H. Soonpaa
Mark H. Soonpaa
HRHans Reinecke
Hans Reinecke
HNHidehiro Nakajima
Hidehiro Nakajima
HNHisako O. Nakajima
Hisako O. Nakajima
LFLoren J. Field
Loren J. Field

6 February 2007 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
JNJeannette Nussbaum
Jeannette Nussbaum
EMElina Minami
Elina Minami
MLMichael A. Laflamme
Michael A. Laflamme
JVJitka A.I. Virag
Jitka A.I. Virag
CWCarol B. Ware
Carol B. Ware
CMCharles E. Murry
Charles E. Murry

1 December 2003 in The American Journal of Pathology
Verified
Journal Article
Closed access
JVJitka A.I. Virag
Jitka A.I. Virag
CMCharles E. Murry
Charles E. Murry

1 November 2007 in The American Journal of Pathology
Verified
Journal Article
Closed access
JVJitka A.I. Virag
Jitka A.I. Virag
MRMarsha L. Rolle
Marsha L. Rolle
JRJulia Reece
Julia Reece
SHSandrine Hardouin
Sandrine Hardouin
EFEric O. Feigl
Eric O. Feigl
CMCharles E. Murry
Charles E. Murry

30 March 2011 in The Journal of Physiology
Verified
Journal Article
Closed access
JDJessica L. Dries
Jessica L. Dries
SKSusan D. Kent
Susan D. Kent
JVJitka A.I. Virag
Jitka A.I. Virag

7 June 2011 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
JVJitka A.I. Virag
Jitka A.I. Virag
RLRobert M. Lust
Robert M. Lust
Mouse models are a valuable tool for studying acute injury and chronic remodeling of the myocardium in vivo. With the advent of genetic modifications to the whole organism or the myocardium and an array of biological and/or synthetic materials, there is great potential for any combination of these to assuage the extent of acute ischemic injury and impede the onset of heart failure pursuant to myocardial remodeling. Here we present the methods and materials used to reliably perform this microsurgery and the modifications involved for temporary (with reperfusion) or permanent coronary artery occlusion studies as well as intramyocardial injections. The effects on the heart that can be seen during the procedure and at the termination of the experiment in addition to histological evaluation will verify efficacy. Briefly, surgical preparation involves anesthetizing the mice, removing the fur on the chest, and then disinfecting the surgical area. Intratracheal intubation is achieved by transesophageal illumination using a fiber optic light. The tubing is then connected to a ventilator. An incision made on the chest exposes the pectoral muscles which will be cut to view the ribs. For ischemia/reperfusion studies, a 1 cm piece of PE tubing placed over the heart is used to tie the ligature to so that occlusion/reperfusion can be customized. For intramyocardial injections, a Hamilton syringe with sterile 30gauge beveled needle is used. When the myocardial manipulations are complete, the rib cage, the pectoral muscles, and the skin are closed sequentially. Line block analgesia is effected by 0.25% marcaine in sterile saline which is applied to muscle layer prior to closure of the skin. The mice are given a subcutaneous injection of saline and placed in a warming chamber until they are sternally recumbent. They are then returned to the vivarium and housed under standard conditions until the time of tissue collection. At the time of sacrifice, the mice are anesthetized, the heart is arrested in diastole with KCl or BDM, rinsed with saline, and immersed in fixative. Subsequently, routine procedures for processing, embedding, sectioning, and histological staining are performed. Nonsurgical intubation of a mouse and the microsurgical manipulations described make this a technically challenging model to learn and achieve reproducibility. These procedures, combined with the difficulty in performing consistent manipulations of the ligature for timed occlusion(s) and reperfusion or intramyocardial injections, can also affect the survival rate so optimization and consistency are critical.